US President Trump Continues Veklury Treatment

Late on October 3, 2020, the US Physician to the President, Sean Patrick Conley, submitted a written statement to President Donald J. Trump's White House press secretary: "not yet out of the woods," but the medical team "remains cautiously optimistic" about his condition following his coronavirus diagnosis.'

'The plan for tomorrow (October 4th) ... is to continue treatment with Veklury (Remdesivir).'

The U.S. FDA announced on August 28, 2020, it broadened the scope of the existing authorization for Veklury to include treatment of all hospitalized adult and pediatric patients with suspected or laboratory-confirmed COVID-19, irrespective of their severity of the disease.